The prevalence and molecular epidemiology of multidrug-resistant enterobacteriaceae colonization in a pediatric intensive care unit

Infection Control and Hospital Epidemiology

Volumn 37, Issue 5, 2016, Pages 535-543

  Suwantarat, Nuntra ^a,b   Logan, Latania K ^c   Carroll, Karen C ^a   Bonomo, Robert A ^d,e   Simner, Patricia J ^a   Rudin, Susan D ^e   Milstone, Aaron M ^d,f   Tekle, Tsigereda ^a   Ross, Tracy ^a   Tamma, Pranita D ^f  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b THAMMASAT UNIVERSITY   (Thailand)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

^d LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^e CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; CARBAPENEM DERIVATIVE; CARBAPENEMASE; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CHAPERONIN 60; EXTENDED SPECTRUM BETA LACTAMASE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; AMPC BETA-LACTAMASES; BACTERIAL DNA; BACTERIAL PROTEIN; BETA LACTAMASE;

ADOLESCENT; ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BETA LACTAMASE AMPC PRODUCING ENTEROBACTERIACEAE; CARBAPENEMASE PRODUCING ENTEROBACTERIACEAE; CHILD; CITROBACTER; CONTROLLED STUDY; DNA MICROARRAY; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE; ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; FEMALE; HOSPITALIZATION; HUMAN; INFANT; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; MOLECULAR EPIDEMIOLOGY; MORGANELLA MORGANII; MULTIDRUG RESISTANCE; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PHYLOGENY; POLYMERASE CHAIN REACTION; PREVALENCE; PROSPECTIVE STUDY; PROTEUS MIRABILIS; SERRATIA MARCESCENS; ENTEROBACTERIACEAE INFECTIONS; FECES; GENETICS; ISOLATION AND PURIFICATION; MARYLAND; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; NEWBORN; PEDIATRIC INTENSIVE CARE UNIT; PRESCHOOL CHILD; PROCEDURES; YOUNG ADULT;

ADOLESCENT; BACTERIAL PROTEINS; BETA-LACTAMASES; CHILD; CHILD, PRESCHOOL; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; ESCHERICHIA COLI; FECES; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INTENSIVE CARE UNITS, PEDIATRIC; MALE; MARYLAND; MICROBIAL SENSITIVITY TESTS; MOLECULAR EPIDEMIOLOGY; MULTILOCUS SEQUENCE TYPING; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84964203198     PISSN: 0899823X     EISSN: 15596834     Source Type: Journal    
DOI: 10.1017/ice.2016.16     Document Type: Article

References (35)

1. Lukac PJ, Bonomo RA, Logan LK. Extended-spectrum betalactamase-producing Enterobacteriaceae in children: old foe, emerging threat. Clin Infect Dis. 2015; 60: 1389-1397.
2. Logan LK. Carbapenem-resistant enterobacteriaceae: an emerging problem in children. Clin Infect Dis. 2012; 55: 852-859.
3. Cantey JB, Sreeramoju P, Jaleel M, et al. Prompt control of an outbreak caused by extended-spectrum beta-lactamaseproducing Klebsiella pneumoniae in a neonatal intensive care unit. J Pediatr. 2013; 163: 672-679; e1-3.
4. Tamma PD, Savard P, Pal T, Sonnevend A, Perl TM, Milstone AM. An outbreak of extended-spectrum betalactamase-producing Klebsiella pneumoniae in a neonatal intensive care unit. Infect Control Hosp Epidemiol. 2012; 33: 631-634.
5. Abdel-Hady H, Hawas S, El-Daker M, El-Kady R. Extendedspectrum beta-lactamase producing Klebsiella pneumoniae in neonatal intensive care unit. J Perinatol. 2008; 28: 685-690.
6. Stone PW, Gupta A, LoughreyM, et al. Attributable costs and length of stay of an extended-spectrum beta-lactamase-producing Klebsiella pneumoniae outbreak in a neonatal intensive care unit. Infect Control Hosp Epidemiol. 2003; 24: 601-606.
7. Huang Y, Zhuang S, Du M. Risk factors of nosocomial infection with extended-spectrum beta-lactamase-producing bacteria in a neonatal intensive care unit in China. Infection. 2007; 35: 339-345.
8. Qin X, Zerr DM, Weissman SJ, et al. Prevalence and mechanisms of broad-spectrum beta-lactam resistance in Enterobacteriaceae: a childrens hospital experience. Antimicrob Agents Chemother. 2008; 52: 3909-3914.
9. Weissman SJ, Adler A, Qin X, Zerr DM. Emergence of extendedspectrum beta-lactam resistance among Escherichia coli at a US academic childrens hospital is clonal at the sequence type level for CTX-M-15, but not for CMY-2. Int J Antimicrob Agents. 2013; 41: 414-420.
10. Blaschke AJ, Korgenski EK, Daly JA, LaFleur B, Pavia AT, Byington CL. Extended-spectrum beta-lactamase-producing pathogens in a childrens hospital: a 5-year experience. Am J Infect Control. 2009; 37: 435-441.
11. Chandramohan L, Revell PA. Prevalence and molecular characterization of extended-spectrum-beta-lactamase-producing Enterobacteriaceae in a pediatric patient population. Antimicrob Agents Chemother. 2012; 56: 4765-4770.
12. User Manual, Check-MDR CT103XL. Check-Points Rapid Molecular Detection website. http://www.check-points.eu/.downloads/Check-MDR-CT103XL-IFU-022-01-EN-01aug2014. pdf. Accessed 13 July 2015.
13. Tartof SY, Solberg OD, Manges AR, Riley LW. Analysis of a uropathogenic Escherichia coli clonal group by multilocus sequence typing. J Clin Microbiol. 2005; 43: 5860-5864.
14. Diancourt L, Passet V, Verhoef J, Grimont PA, Brisse S. Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates. J Clin Microbiol. 2005; 43: 4178-4182.
15. Mathers AJ, Peirano G, Pitout JD. The role of epidemic resistance plasmids and international high-risk clones in the spread of multidrug-resistant Enterobacteriaceae. Clin Microbiol Rev. 2015; 28: 565-591.
16. Pitout JD, Campbell L, Church DL, Wang PW, Guttman DS, Gregson DB. Using a commercial DiversiLab semiautomated repetitive sequence-based PCR typing technique for identification of Escherichia coli clone ST131 producing CTX-M-15. J Clin Microbiol. 2009; 47: 1212-1215.
17. Hoffmann H, Roggenkamp A. Population genetics of the nomenspecies Enterobacter cloacae. Appl Environ Microbiol. 2003; 69: 5306-5318.
18. Kiedrowski LM, Guerrero DM, Perez F, et al. Carbapenemresistant Enterobacter cloacae isolates producing KPC-3, North Dakota, USA. Emerging Infect Dis. 2014; 20: 1583-1585.
19. Clermont O, Bonacorsi S, Bingen E. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol. 2000; 66: 4555-4558.
20. Tschudin-Sutter S, Frei R, Dangel M, Stranden A, Widmer AF. Rate of transmission of extended-spectrum beta-lactamaseproducing enterobacteriaceae without contact isolation. Clin Infect Dis. 2012; 55: 1505-1511.
21. Tschudin-Sutter S, Frei R, Dangel M, Stranden A, Widmer AM. Nosocomial spread of extended-spectrum beta-lactamases (ESBL)-producing Enterobacteriaceae without contact isolation: a prospective observational study. Abstract 0121 presented at the 22nd European Congress of Clinical Microbiology and Infectious Diseases, March 31-April 3, 2012, London, United Kingdom
22. Ohmagari N, Kurai H, Yamagishi Y, Mikamo H. Are strict isolation policies based on susceptibility testing actually effective in the prevention of the nosocomial spread of multi-drugresistant Gram-negative rods?. Am J Infect Control. 2014; 42: 739-743.
23. Han JH, Bilker WB, Nachamkin I, et al. The effect of a hospitalwide urine culture screening intervention on the incidence of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species. Infect Control Hosp Epidemiol. 2013; 34: 1160-1166.
24. Hilty M, Betsch BY, Bogli-Stuber K, et al. Transmission dynamics of extended-spectrum beta-lactamase-producing Enterobacteriaceae in the tertiary care hospital and the household setting. Clin Infect Dis. 2012; 55: 967-975.
25. Dayan N, Dabbah H, Weissman I, Aga I, Even L, Glikman D. Urinary tract infections caused by community-Acquired extended-spectrum beta-lactamase-producing and nonproducing bacteria: a comparative study. J Pediatr. 2013; 163: 1417-1421.
26. Fan NC, Chen HH, Chen CL, et al. Rise of community-onset urinary tract infection caused by extended-spectrum betalactamase-producing Escherichia coli in children. J Microbiol Immunol Infect. 2014; 47: 399-405.
27. Megged O. Extended-spectrum beta-lactamase-producing bacteria causing community-Acquired urinary tract infections in children. Pediatric Nephrol. 2014; 29: 1583-1587.
28. Morgand M, Vimont S, Bleibtreu A, et al. Extended-spectrum beta-lactamase-producing Escherichia coli infections in children: are community-Acquired strains different from nosocomial strains?. Int J Med Microbiol. 2014; 304: 970-976.
29. Madigan T, Johnson JR, Clabots C, et al. Extensive household outbreak of urinary tract infection and intestinal colonization due to extended-spectrum beta-lactamase-producing Escherichia coli sequence type 131. Clin Infect Dis. 2015; 61: e5-e12.
30. Kaarme J, Molin Y, Olsen B, Melhus A. Prevalence of extended-spectrum beta-lactamase-producing Enterobacteriaceae in healthy Swedish preschool children. Acta paediatrica. 2013; 102: 655-660.
31. Guh AY, Bulens SN, Jacob JT, et al. Epidemiology of carbapenem-resistant Enterobacteriaceae in 7 US Communities, 2012-2013. J Am Med Asso. 2015; 314: 1479-1487.
32. Logan LK, Renschler JP, Gandra S, et al. Carbapenem-resistant Enterobacteriaceae in children, United States, 1999-2012. Emerg Infect Dis. 2015; 21: 2014-2021.
33. Chiotos K, Han J, Tamma PD. Carbapenem-resistant Enterobacteriaceae infections in children. Curr Infect Dis Rept 2016 Jan18: 2. doi: 10.1007/s11908-015-0510-9.
34. Marik PE, Hedman L. Whats in a day?. Determining intensive care unit length of stay. Crit Care Med. 2000; 28: 2090-2093.
35. Weissman C. Analyzing intensive care unit length of stay data: problems and possible solutions. Crit Care Med. 1997; 25: 1594-1600.